PRAVEEN TYLE - 14 Sep 2021 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/Praveen Tyle, Ph.D.
Issuer symbol
SKYE
Transactions as of
14 Sep 2021
Net transactions value
$0
Form type
4
Filing time
16 Sep 2021, 16:01:10 UTC
Previous filing
26 Jul 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Director Stock Option (Right to Buy) Award $0 +25,000 +10% $0.000000 275,000 14 Sep 2021 Common Stock 25,000 $0.1200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option shall be exercisable for a price of $0.12 per Option Share in twelve equal monthly installments such that all the Option Shares shall vest in twelve months.